Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data.
Yousif SubhiJakob BjeragerCamiel J F BoonElon H C Van DijkPublished in: Acta ophthalmologica (2021)
SRF morphology changed after both HSML treatment and half-dose PDT in cCSC, with SRF disappearing in most PDT-treated patients, whereas SRF volume increased in a sizeable proportion of HSML-treated patients. Baseline SRF characteristics measured in this study were unable to predict outcomes after either HSML treatment or half-dose PDT.
Keyphrases
- end stage renal disease
- newly diagnosed
- photodynamic therapy
- chronic kidney disease
- ejection fraction
- prognostic factors
- clinical trial
- randomized controlled trial
- machine learning
- combination therapy
- electronic health record
- patient reported outcomes
- artificial intelligence
- deep learning
- smoking cessation
- open label
- big data